Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos
{"title":"Guía mexicana para el diagnóstico y el tratamiento del hemangioma infantil.","authors":"Mirna E Toledo-Bahena, Karen A Camargo-Sánchez, Helena Vidaurri-De la Cruz, Adriana M Valencia-Herrera, M Mar Sáez-de Ocáriz, Mario R Duarte-Abdala, Julieta Osuna-Osuna, Jessica Aranda-Mendoza, Gloria M Rosales-Solís, Gibert Maza-Ramos, M Luz Orozco-Covarrubias, Pablo Lezama-Del Valle, Julio R Erdmenger-Orellana, Rocío Enríquez-García, Pilar Dies-Suárez, Alejandro Celis-Jiménez, Carlos A Mena-Cedillos","doi":"10.24875/BMHIM.24000069","DOIUrl":null,"url":null,"abstract":"<p><p>Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"81 Supl 2","pages":"1-28"},"PeriodicalIF":0.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boletín médico del Hospital Infantil de México","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/BMHIM.24000069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Infantile hemangioma is a benign vascular tumor, the most common in childhood, whose natural evolution is the disappearance of the lesion in the pediatric age and which has effective and safe treatments that limit its growth and favor its disappearance at younger ages. Infantile hemangioma continues to be a reason for attention to complications, due to erroneous diagnoses, lack of knowledge of the condition, late referral or fear of the effects of the medications used for its treatment. Furthermore, its presence is normalized without taking into account that it can cause uncertainty, anxiety, feelings of guilt and, as a consequence, a significant impact on the quality of life, mainly in the parents or caregivers of the child. The need for a clinical practice guideline in our country arises from the high presentation of late-remitted complications in infantile hemangioma even with the availability of adequate treatments, the continuous evolution of medicine and the appearance of new evidence. Throughout the guide you will find recommendations regarding the diagnosis, treatment and follow-up of patients with infantile hemangioma, taking into account the paraclinical tests that can be performed, topical or systemic management options, as well as adjuvant therapies. For the first time, objective tools for patient follow-up are included in a guide for the management of infantile hemangioma, as well as to help the first contact doctor in timely referral.
期刊介绍:
The Boletín Médico del Hospital Infantil de México is a bimonthly publication edited by the Hospital Infantil de México Federico Gómez. It receives unpublished manuscripts, in English or Spanish, relating to paediatrics in the following areas: biomedicine, clinical, public health, clinical epidemology, health education and clinical ethics. Articles can be original research articles, in-depth or systematic reviews, clinical cases, clinical-pathological cases, articles about public health, letters to the editor or editorials (by invitation).